Kirin-Amgen, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kirin-Amgen, Inc..The latest application filed is for "method of treating psoriasis using an il-17 receptor antibody formulation".
- Kirin-Amgen, Inc. - Thousand Oaks CA US
- Kirin-Amgen, Inc. -
- KIRIN-AMGEN, INC. - One Amgen Center Drive Thousand Oaks CA
- Kirin-Amgen, Inc. - Tokyo JP
- Kirin-Amgen Inc. - Wilmington DE
| Patent | Date |
|---|---|
| Method Of Treating Psoriasis Using An Il-17 Receptor Antibody Formulation App 20180346583 - Liu; Dingjiang ; et al. | 2018-12-06 |
| Method of treating psoriasis using an IL-17 receptor antibody formulation Grant 10,072,085 - Liu , et al. September 11, 2 | 2018-09-11 |
| Method For Treating Psoriasis Patient Which Received Anti-tnf-alpha Antibody Therapy App 20170298136 - NAKAGAWA; Hidemi ; et al. | 2017-10-19 |
| Methods Of Treating Nail And Scalp Psoriasis App 20170174772 - Nirula; Ajay ; et al. | 2017-06-22 |
| Il-17ra-il-17rb Antagonists And Uses Thereof App 20170114140 - Budelsky; Alison L. ; et al. | 2017-04-27 |
| Il-17 Receptor A Antigen Binding Proteins App 20160251443 - Tocker; Joel E. ; et al. | 2016-09-01 |
| IL-17 receptor A antigen binding proteins Grant 9,096,673 - Tocker , et al. August 4, 2 | 2015-08-04 |
| Anti-IL-17 receptor A neutralizing antibodies Grant 9,073,999 - Tocker , et al. July 7, 2 | 2015-07-07 |
| IL-17 Receptor Antibody Formulation App 20150017184 - Liu; Dingjiang ; et al. | 2015-01-15 |
| IL-17 receptor antibody formulation Grant 8,883,151 - Liu , et al. November 11, 2 | 2014-11-11 |
| Polynucleotides encoding IL-17 receptor A antigen binding proteins Grant 8,545,842 - Tocker , et al. October 1, 2 | 2013-10-01 |
| Methods of using IL-17 receptor a antibodies Grant 8,435,518 - Tocker , et al. May 7, 2 | 2013-05-07 |
| High Molecular Weight Medicine-containing Preparation In Powder Form For Administration Through Mucosa App 20090028814 - Nomura; Hideaki ; et al. | 2009-01-29 |
| Chemically modified G-CSF App 20070219357 - Ishikawa; Rika ; et al. | 2007-09-20 |
| Chemically modified G-CSF App 20060247422 - Ishikawa; Rika ; et al. | 2006-11-02 |
| High molecular weight medicine-containing preparation in powder form for administration through mucosa App 20050271728 - Nomura, Hideaki ; et al. | 2005-12-08 |
| Chemically-modified G-CSF App 20040204566 - Ishikawa, Rika ; et al. | 2004-10-14 |
| Chemically modified G-CSF App 20040158041 - Ishikawa, Rika ; et al. | 2004-08-12 |
| Chemically-modified G-CSF App 20020177688 - Ishikawa, Rika ; et al. | 2002-11-28 |
| Chemically-modified G-CSF Grant 6,166,183 - Ishikawa , et al. December 26, 2 | 2000-12-26 |
| Production of erthropoietin Grant 5,955,422 - Lin Sept | 1999-09-21 |
| Chemically-modified G-CSF Grant 5,824,778 - Ishikawa , et al. October 20, 1 | 1998-10-20 |
| Production of erythropoietin Grant 5,621,080 - Lin * | 1997-04-15 |
| Production of erythropoietin Grant 5,618,698 - Lin * | 1997-04-08 |
| Oral dosage form of biologically active proteins Grant 5,597,562 - Nomura , et al. January 28, 1 | 1997-01-28 |
| Production of erythropoietin Grant 5,547,933 - Lin A | 1996-08-20 |
| Monoclonal antibodies and method for the determination of human G-CSF Grant 5,468,846 - Ichikawa , et al. November 21, 1 | 1995-11-21 |
| Production of recombinant erythropoietin Grant 5,441,868 - Lin A | 1995-08-15 |
| Modified HIL-6 Grant 5,264,209 - Mikayama , et al. November 23, 1 | 1993-11-23 |
| Production of pluripotent granulocyte colony-stimulating factor Grant 4,810,643 - Souza March 7, 1 | 1989-03-07 |
| Erythropoietin purification Grant 4,667,016 - Lai , et al. May 19, 1 | 1987-05-19 |
| A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin Grant 4,558,006 - Egrie December 10, 1 | 1985-12-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 